US Patent Issued to IMBRIA PHARMACEUTICALS on June 3 for "Methods of treating rheumatic diseases using trimetazidine-based compounds" (California, Massachusetts, North Carolina Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,382, issued on June 3, was assigned to IMBRIA PHARMACEUTICALS INC. (Boston).

"Methods of treating rheumatic diseases using trimetazidine-based compounds" was invented by Andrew D. Levin (Newton, Mass.), David-Alexandre Gros (Rancho Santa Fe, Calif.) and Jaikrishna Patel (Cary, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating a subject having a rheumatic condition."

The patent was filed on Oct. 10, 2019, under Application No. 17/282,584.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2...